nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivaroxaban—F10—Blood Clotting Cascade—KLK1—pancreatitis	0.0484	0.0692	CbGpPWpGaD
Rivaroxaban—Dermatitis atopic—Propantheline—pancreatitis	0.0362	0.12	CcSEcCtD
Rivaroxaban—F10—Common Pathway—FGG—pancreatitis	0.0313	0.0448	CbGpPWpGaD
Rivaroxaban—F10—Blood Clotting Cascade—FGG—pancreatitis	0.0267	0.0381	CbGpPWpGaD
Rivaroxaban—F10—Common Pathway—FGA—pancreatitis	0.0266	0.0381	CbGpPWpGaD
Rivaroxaban—F10—Intrinsic Pathway—A2M—pancreatitis	0.0248	0.0354	CbGpPWpGaD
Rivaroxaban—F10—Common Pathway—FGB—pancreatitis	0.0242	0.0346	CbGpPWpGaD
Rivaroxaban—F10—Blood Clotting Cascade—FGA—pancreatitis	0.0227	0.0324	CbGpPWpGaD
Rivaroxaban—F10—Beta2 integrin cell surface interactions—FGG—pancreatitis	0.0214	0.0306	CbGpPWpGaD
Rivaroxaban—F10—Blood Clotting Cascade—FGB—pancreatitis	0.0206	0.0295	CbGpPWpGaD
Rivaroxaban—CYP2J2—Cytochrome P450 - arranged by substrate type—FDX1—pancreatitis	0.0205	0.0293	CbGpPWpGaD
Rivaroxaban—F10—Beta2 integrin cell surface interactions—FGA—pancreatitis	0.0182	0.026	CbGpPWpGaD
Rivaroxaban—F10—Formation of Fibrin Clot (Clotting Cascade)—FGG—pancreatitis	0.018	0.0257	CbGpPWpGaD
Rivaroxaban—F10—Formation of Fibrin Clot (Clotting Cascade)—A2M—pancreatitis	0.0167	0.0239	CbGpPWpGaD
Rivaroxaban—CYP2J2—Phase 1 - Functionalization of compounds—FDX1—pancreatitis	0.0166	0.0237	CbGpPWpGaD
Rivaroxaban—F10—Beta2 integrin cell surface interactions—FGB—pancreatitis	0.0165	0.0236	CbGpPWpGaD
Rivaroxaban—F10—Intrinsic Pathway—KNG1—pancreatitis	0.0165	0.0236	CbGpPWpGaD
Rivaroxaban—CYP2J2—Phase 1 - Functionalization of compounds—ADH4—pancreatitis	0.0154	0.0221	CbGpPWpGaD
Rivaroxaban—F10—Formation of Fibrin Clot (Clotting Cascade)—FGA—pancreatitis	0.0153	0.0219	CbGpPWpGaD
Rivaroxaban—F10—Formation of Fibrin Clot (Clotting Cascade)—FGB—pancreatitis	0.0139	0.0199	CbGpPWpGaD
Rivaroxaban—F10—Beta2 integrin cell surface interactions—KNG1—pancreatitis	0.0132	0.0189	CbGpPWpGaD
Rivaroxaban—Blood urea increased—Hyoscyamine—pancreatitis	0.0129	0.0431	CcSEcCtD
Rivaroxaban—CYP2J2—Tryptophan metabolism—ALDH2—pancreatitis	0.0124	0.0177	CbGpPWpGaD
Rivaroxaban—CYP2J2—Phase 1 - Functionalization of compounds—ADH1B—pancreatitis	0.0115	0.0165	CbGpPWpGaD
Rivaroxaban—Swelling—Hyoscyamine—pancreatitis	0.0113	0.0375	CcSEcCtD
Rivaroxaban—F10—Formation of Fibrin Clot (Clotting Cascade)—KNG1—pancreatitis	0.0111	0.0159	CbGpPWpGaD
Rivaroxaban—F10—Complement and Coagulation Cascades—SERPINA1—pancreatitis	0.0106	0.0151	CbGpPWpGaD
Rivaroxaban—Osteoarthritis—Hyoscyamine—pancreatitis	0.00995	0.0331	CcSEcCtD
Rivaroxaban—Dry mouth—Propantheline—pancreatitis	0.00974	0.0324	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Propantheline—pancreatitis	0.00955	0.0318	CcSEcCtD
Rivaroxaban—F10—Complement and Coagulation Cascades—FGB—pancreatitis	0.00937	0.0134	CbGpPWpGaD
Rivaroxaban—Tachycardia—Propantheline—pancreatitis	0.00932	0.031	CcSEcCtD
Rivaroxaban—CYP2J2—Biological oxidations—FDX1—pancreatitis	0.00882	0.0126	CbGpPWpGaD
Rivaroxaban—F10—Beta2 integrin cell surface interactions—ICAM1—pancreatitis	0.00851	0.0122	CbGpPWpGaD
Rivaroxaban—Angina pectoris—Hyoscyamine—pancreatitis	0.00837	0.0279	CcSEcCtD
Rivaroxaban—CYP2J2—Biological oxidations—ADH4—pancreatitis	0.0082	0.0117	CbGpPWpGaD
Rivaroxaban—Constipation—Propantheline—pancreatitis	0.00817	0.0272	CcSEcCtD
Rivaroxaban—CYP2J2—Phase 1 - Functionalization of compounds—ALDH2—pancreatitis	0.00811	0.0116	CbGpPWpGaD
Rivaroxaban—Feeling abnormal—Propantheline—pancreatitis	0.00787	0.0262	CcSEcCtD
Rivaroxaban—Urticaria—Propantheline—pancreatitis	0.00759	0.0253	CcSEcCtD
Rivaroxaban—F10—Complement and Coagulation Cascades—KNG1—pancreatitis	0.00749	0.0107	CbGpPWpGaD
Rivaroxaban—CYP3A4—Fatty Acid Omega Oxidation—ADH4—pancreatitis	0.00735	0.0105	CbGpPWpGaD
Rivaroxaban—ABCB1—ABC-family proteins mediated transport—CFTR—pancreatitis	0.00733	0.0105	CbGpPWpGaD
Rivaroxaban—Hypersensitivity—Propantheline—pancreatitis	0.00704	0.0234	CcSEcCtD
Rivaroxaban—Asthenia—Propantheline—pancreatitis	0.00685	0.0228	CcSEcCtD
Rivaroxaban—Dizziness—Propantheline—pancreatitis	0.00632	0.021	CcSEcCtD
Rivaroxaban—CYP2J2—Biological oxidations—ADH1B—pancreatitis	0.00611	0.00874	CbGpPWpGaD
Rivaroxaban—Vomiting—Propantheline—pancreatitis	0.00607	0.0202	CcSEcCtD
Rivaroxaban—Rash—Propantheline—pancreatitis	0.00602	0.02	CcSEcCtD
Rivaroxaban—Dermatitis—Propantheline—pancreatitis	0.00602	0.02	CcSEcCtD
Rivaroxaban—Headache—Propantheline—pancreatitis	0.00598	0.0199	CcSEcCtD
Rivaroxaban—CYP3A5—Cytochrome P450 - arranged by substrate type—FDX1—pancreatitis	0.0059	0.00844	CbGpPWpGaD
Rivaroxaban—Nausea—Propantheline—pancreatitis	0.00567	0.0189	CcSEcCtD
Rivaroxaban—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—pancreatitis	0.00548	0.00783	CbGpPWpGaD
Rivaroxaban—Angioedema—Hyoscyamine—pancreatitis	0.00547	0.0182	CcSEcCtD
Rivaroxaban—Syncope—Hyoscyamine—pancreatitis	0.00537	0.0179	CcSEcCtD
Rivaroxaban—Loss of consciousness—Hyoscyamine—pancreatitis	0.00526	0.0175	CcSEcCtD
Rivaroxaban—Chest pain—Hyoscyamine—pancreatitis	0.0051	0.017	CcSEcCtD
Rivaroxaban—Dry mouth—Hyoscyamine—pancreatitis	0.00499	0.0166	CcSEcCtD
Rivaroxaban—Anaphylactic shock—Hyoscyamine—pancreatitis	0.00489	0.0163	CcSEcCtD
Rivaroxaban—Oedema—Hyoscyamine—pancreatitis	0.00489	0.0163	CcSEcCtD
Rivaroxaban—Shock—Hyoscyamine—pancreatitis	0.00481	0.016	CcSEcCtD
Rivaroxaban—CYP3A5—Phase 1 - Functionalization of compounds—FDX1—pancreatitis	0.00479	0.00684	CbGpPWpGaD
Rivaroxaban—Tachycardia—Hyoscyamine—pancreatitis	0.00477	0.0159	CcSEcCtD
Rivaroxaban—Hypotension—Hyoscyamine—pancreatitis	0.00457	0.0152	CcSEcCtD
Rivaroxaban—CYP3A5—Phase 1 - Functionalization of compounds—ADH4—pancreatitis	0.00445	0.00636	CbGpPWpGaD
Rivaroxaban—CYP2J2—Tryptophan metabolism—MDM2—pancreatitis	0.00438	0.00627	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—STXBP3—pancreatitis	0.00436	0.00623	CbGpPWpGaD
Rivaroxaban—Dyspnoea—Hyoscyamine—pancreatitis	0.00436	0.0145	CcSEcCtD
Rivaroxaban—CYP2J2—Biological oxidations—ALDH2—pancreatitis	0.00431	0.00616	CbGpPWpGaD
Rivaroxaban—Dyspepsia—Hyoscyamine—pancreatitis	0.0043	0.0143	CcSEcCtD
Rivaroxaban—Fatigue—Hyoscyamine—pancreatitis	0.00421	0.014	CcSEcCtD
Rivaroxaban—Pain—Hyoscyamine—pancreatitis	0.00418	0.0139	CcSEcCtD
Rivaroxaban—Constipation—Hyoscyamine—pancreatitis	0.00418	0.0139	CcSEcCtD
Rivaroxaban—Feeling abnormal—Hyoscyamine—pancreatitis	0.00403	0.0134	CcSEcCtD
Rivaroxaban—Gastrointestinal pain—Hyoscyamine—pancreatitis	0.004	0.0133	CcSEcCtD
Rivaroxaban—CYP2J2—Arachidonic acid metabolism—PTGS2—pancreatitis	0.00395	0.00565	CbGpPWpGaD
Rivaroxaban—Urticaria—Hyoscyamine—pancreatitis	0.00388	0.0129	CcSEcCtD
Rivaroxaban—Abdominal pain—Hyoscyamine—pancreatitis	0.00386	0.0129	CcSEcCtD
Rivaroxaban—CYP3A4—Fatty Acid Omega Oxidation—ALDH2—pancreatitis	0.00386	0.00552	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—CPB1—pancreatitis	0.00365	0.00521	CbGpPWpGaD
Rivaroxaban—Hypersensitivity—Hyoscyamine—pancreatitis	0.0036	0.012	CcSEcCtD
Rivaroxaban—Asthenia—Hyoscyamine—pancreatitis	0.00351	0.0117	CcSEcCtD
Rivaroxaban—Pruritus—Hyoscyamine—pancreatitis	0.00346	0.0115	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—FDX1—pancreatitis	0.00339	0.00484	CbGpPWpGaD
Rivaroxaban—Diarrhoea—Hyoscyamine—pancreatitis	0.00334	0.0111	CcSEcCtD
Rivaroxaban—CYP3A5—Phase 1 - Functionalization of compounds—ADH1B—pancreatitis	0.00332	0.00474	CbGpPWpGaD
Rivaroxaban—Dizziness—Hyoscyamine—pancreatitis	0.00323	0.0108	CcSEcCtD
Rivaroxaban—Vomiting—Hyoscyamine—pancreatitis	0.00311	0.0103	CcSEcCtD
Rivaroxaban—F10—Metabolism of proteins—KLK1—pancreatitis	0.0031	0.00443	CbGpPWpGaD
Rivaroxaban—Rash—Hyoscyamine—pancreatitis	0.00308	0.0103	CcSEcCtD
Rivaroxaban—Dermatitis—Hyoscyamine—pancreatitis	0.00308	0.0103	CcSEcCtD
Rivaroxaban—Headache—Hyoscyamine—pancreatitis	0.00306	0.0102	CcSEcCtD
Rivaroxaban—Nausea—Hyoscyamine—pancreatitis	0.0029	0.00967	CcSEcCtD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PNLIP—pancreatitis	0.00281	0.00401	CbGpPWpGaD
Rivaroxaban—CYP3A4—Cytochrome P450 - arranged by substrate type—FDX1—pancreatitis	0.00275	0.00392	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—FDX1—pancreatitis	0.00254	0.00363	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—SELL—pancreatitis	0.00244	0.00348	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—ADH4—pancreatitis	0.00236	0.00338	CbGpPWpGaD
Rivaroxaban—CYP3A5—Phase 1 - Functionalization of compounds—ALDH2—pancreatitis	0.00234	0.00334	CbGpPWpGaD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—FDX1—pancreatitis	0.00223	0.00318	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—FGG—pancreatitis	0.00217	0.0031	CbGpPWpGaD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—ADH4—pancreatitis	0.00207	0.00296	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—A2M—pancreatitis	0.00202	0.00288	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—SERPINA1—pancreatitis	0.0019	0.00271	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PLA2G1B—pancreatitis	0.00187	0.00268	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—FGA—pancreatitis	0.00185	0.00264	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—A2M—pancreatitis	0.00181	0.00259	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—ADH1B—pancreatitis	0.00176	0.00252	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—CTRB2—pancreatitis	0.00174	0.00249	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—IL13—pancreatitis	0.00169	0.00242	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—FGB—pancreatitis	0.00168	0.0024	CbGpPWpGaD
Rivaroxaban—CYP3A4—Tryptophan metabolism—ALDH2—pancreatitis	0.00166	0.00237	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—pancreatitis	0.00164	0.00234	CbGpPWpGaD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—pancreatitis	0.00154	0.0022	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—FDX1—pancreatitis	0.00151	0.00216	CbGpPWpGaD
Rivaroxaban—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatitis	0.00149	0.00213	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ADH4—pancreatitis	0.0014	0.002	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—KNG1—pancreatitis	0.00134	0.00192	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PRSS1—pancreatitis	0.00132	0.00188	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PRSS3—pancreatitis	0.00125	0.00179	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PNLIP—pancreatitis	0.00125	0.00179	CbGpPWpGaD
Rivaroxaban—CYP3A5—Biological oxidations—ALDH2—pancreatitis	0.00124	0.00177	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—PDGFA—pancreatitis	0.00123	0.00176	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—HLA-DQA1—pancreatitis	0.0012	0.00171	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—FDX1—pancreatitis	0.00118	0.00169	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—XDH—pancreatitis	0.00112	0.0016	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—HGF—pancreatitis	0.00112	0.0016	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—GCG—pancreatitis	0.0011	0.00157	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—ADH4—pancreatitis	0.0011	0.00157	CbGpPWpGaD
Rivaroxaban—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—pancreatitis	0.00109	0.00155	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—IL10—pancreatitis	0.00106	0.00151	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ADH1B—pancreatitis	0.00105	0.00149	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—HSP90AB1—pancreatitis	0.00103	0.00148	CbGpPWpGaD
Rivaroxaban—ABCB1—HIF-1-alpha transcription factor network—LEP—pancreatitis	0.00101	0.00144	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—LPL—pancreatitis	0.000984	0.00141	CbGpPWpGaD
Rivaroxaban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatitis	0.000917	0.00131	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—HLA-DRB1—pancreatitis	0.000852	0.00122	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PLA2G1B—pancreatitis	0.000834	0.00119	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—ADH1B—pancreatitis	0.000819	0.00117	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—A2M—pancreatitis	0.000806	0.00115	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—pancreatitis	0.000801	0.00115	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—CFTR—pancreatitis	0.000766	0.00109	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ALDH2—pancreatitis	0.000737	0.00105	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—LEP—pancreatitis	0.000724	0.00103	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—ALB—pancreatitis	0.000721	0.00103	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	0.000718	0.00103	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—ALB—pancreatitis	0.000646	0.000923	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—EGR1—pancreatitis	0.000632	0.000904	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—INS—pancreatitis	0.000618	0.000884	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—CCL2—pancreatitis	0.000608	0.00087	CbGpPWpGaD
Rivaroxaban—CYP3A4—Tryptophan metabolism—MDM2—pancreatitis	0.000587	0.00084	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—CXCL8—pancreatitis	0.000578	0.000827	CbGpPWpGaD
Rivaroxaban—CYP3A4—Biological oxidations—ALDH2—pancreatitis	0.000577	0.000825	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFA—pancreatitis	0.000576	0.000824	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	0.000565	0.000808	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—GCG—pancreatitis	0.000558	0.000798	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—IL1B—pancreatitis	0.000555	0.000793	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—CASP3—pancreatitis	0.000554	0.000791	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—CTRB2—pancreatitis	0.000502	0.000717	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—NRAS—pancreatitis	0.000491	0.000701	CbGpPWpGaD
Rivaroxaban—F10—Metabolism of proteins—CXCL8—pancreatitis	0.000481	0.000688	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—TGFB1—pancreatitis	0.000456	0.000652	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—TRPV1—pancreatitis	0.000451	0.000645	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—LPL—pancreatitis	0.000438	0.000626	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—FDX1—pancreatitis	0.000435	0.000622	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—TGFB1—pancreatitis	0.000431	0.000616	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—KRAS—pancreatitis	0.000422	0.000604	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ADH4—pancreatitis	0.000404	0.000578	CbGpPWpGaD
Rivaroxaban—ABCB1—Allograft Rejection—TNF—pancreatitis	0.000403	0.000576	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PRSS1—pancreatitis	0.00038	0.000543	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—CTRB2—pancreatitis	0.000378	0.000541	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PNLIP—pancreatitis	0.00036	0.000515	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PRSS3—pancreatitis	0.00036	0.000515	CbGpPWpGaD
Rivaroxaban—F10—Hemostasis—HRAS—pancreatitis	0.000359	0.000513	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—FDX1—pancreatitis	0.000328	0.000469	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—XDH—pancreatitis	0.000323	0.000462	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PPARG—pancreatitis	0.00032	0.000457	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—INS—pancreatitis	0.000314	0.000448	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—pancreatitis	0.000305	0.000436	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ADH4—pancreatitis	0.000305	0.000436	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ADH1B—pancreatitis	0.000301	0.000431	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatitis	0.000294	0.000421	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—ALB—pancreatitis	0.000288	0.000411	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PRSS1—pancreatitis	0.000287	0.00041	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatitis	0.000273	0.000391	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PNLIP—pancreatitis	0.000272	0.000389	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PRSS3—pancreatitis	0.000272	0.000389	CbGpPWpGaD
Rivaroxaban—CYP2J2—Metabolism—PTGS2—pancreatitis	0.000252	0.00036	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—XDH—pancreatitis	0.000244	0.000349	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PLA2G1B—pancreatitis	0.00024	0.000344	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—CTRB2—pancreatitis	0.000233	0.000333	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—A2M—pancreatitis	0.000232	0.000332	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ADH1B—pancreatitis	0.000227	0.000325	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatitis	0.000213	0.000304	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALDH2—pancreatitis	0.000212	0.000304	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—FDX1—pancreatitis	0.000202	0.000289	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatitis	0.000199	0.000284	CbGpPWpGaD
Rivaroxaban—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatitis	0.000197	0.000282	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ADH4—pancreatitis	0.000188	0.000269	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PLA2G1B—pancreatitis	0.000181	0.000259	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PRSS1—pancreatitis	0.000177	0.000253	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—A2M—pancreatitis	0.000175	0.00025	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PRSS3—pancreatitis	0.000168	0.000239	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PNLIP—pancreatitis	0.000168	0.000239	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—GCG—pancreatitis	0.000161	0.00023	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALDH2—pancreatitis	0.00016	0.000229	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—XDH—pancreatitis	0.00015	0.000215	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ADH1B—pancreatitis	0.00014	0.0002	CbGpPWpGaD
Rivaroxaban—ABCB1—Transmembrane transport of small molecules—ALB—pancreatitis	0.000134	0.000191	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—LPL—pancreatitis	0.000126	0.000181	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—GCG—pancreatitis	0.000121	0.000174	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PLA2G1B—pancreatitis	0.000112	0.00016	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—A2M—pancreatitis	0.000108	0.000154	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALDH2—pancreatitis	9.87e-05	0.000141	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—LPL—pancreatitis	9.53e-05	0.000136	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PPARG—pancreatitis	9.22e-05	0.000132	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—INS—pancreatitis	9.04e-05	0.000129	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—ALB—pancreatitis	8.29e-05	0.000119	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—GCG—pancreatitis	7.48e-05	0.000107	CbGpPWpGaD
Rivaroxaban—CYP3A5—Metabolism—PTGS2—pancreatitis	7.25e-05	0.000104	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PPARG—pancreatitis	6.96e-05	9.95e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—INS—pancreatitis	6.82e-05	9.75e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—ALB—pancreatitis	6.26e-05	8.94e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—LPL—pancreatitis	5.87e-05	8.39e-05	CbGpPWpGaD
Rivaroxaban—ABCB1—Metabolism—PTGS2—pancreatitis	5.47e-05	7.82e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PPARG—pancreatitis	4.29e-05	6.13e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—INS—pancreatitis	4.2e-05	6.01e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—ALB—pancreatitis	3.85e-05	5.51e-05	CbGpPWpGaD
Rivaroxaban—CYP3A4—Metabolism—PTGS2—pancreatitis	3.37e-05	4.82e-05	CbGpPWpGaD
